thymoquinone has been researched along with rotenone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Moldzio, R; Radad, K; Rausch, WD; Taha, M | 1 |
| Ebrahimi, SS; Hassanzadeh, K; Izadpanah, E; Oryan, S | 1 |
3 other study(ies) available for thymoquinone and rotenone
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Thymoquinone protects dopaminergic neurons against MPP+ and rotenone.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Benzoquinones; Cells, Cultured; Dopamine; Insecticides; Mesencephalon; Mice; Neurons; Neuroprotective Agents; Rotenone; Time Factors | 2009 |
Thymoquinone exerts neuroprotective effect in animal model of Parkinson's disease.
Topics: Animals; Antioxidants; Basal Ganglia; Behavior, Animal; Benzoquinones; Cytoprotection; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Dynamins; Male; Motor Activity; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Rats, Wistar; Rotenone; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Ubiquitin-Protein Ligases | 2017 |